BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220610T091000
DTEND;TZID=America/Toronto:20220610T173000
DTSTAMP:20260501T042242
CREATED:20220519T181950Z
LAST-MODIFIED:20220523T061522Z
UID:20098-1654852200-1654882200@scienceinboston.com
SUMMARY:Life Sciences Day – “Belgium\, the Health & Biotech Valley of Tomorrow”
DESCRIPTION:Did you know that Belgium is a vibrant and innovative ecosystem in health and life sciences?  \nBelgium is serving as a covid vaccine production powerhouse to fight the pandemic. The Belgian biopharma industry has been the leader for the European market for the 5th year in a row. \nTop Belgian life sciences companies will host a full-day event at the MassBio Hub on June 10th with the aim to meet and engage US companies and to develop partnerships. This event is taking place within the biggest Belgian trade mission ever organized\, chaired by HRH Princess Astrid\, with a delegation of more than 250 companies. \nIt will be an opportunity to learn\, meet and network with CEOs of established and promising life science companies. (http://www.investinwallonia.be/key-sectors/life-sciences/belgian-economic-mission-life-sciences-usa?organization=3&application=#card-9 ) \nThe program includes conferences\, seminars and B2B meetings\, and\, will end with a pre-Bio networking drink. \nThe day will be divided in 4 different sessions  \n\nSession 1: Biomanufacturing in Belgium – an ecosystem that goes beyond the current assets\n\n\n\n\n\n\nPanel discussion 1 – Health challenges of today and tomorrow: the importance of biomanufacturing capabilities – 35 min with US/BE representatives of Mithra\, Kaneka-Eurogentec\, GSK\, Thermo Fisher\nPanel 2: Innovation in biomanufacturing – 35 min with US/BE representatives of UCB\, Univercells\, Takeda\, BioWin\n\n\n\n\n\n\nSession 2: Artificial Intelligence\, catalyst in Health & Life-Sciences\n\n\n\n\nPresentations by leading researchers followed by panel discussion with US/BE representatives of IMEC\, MIT\, N-Side\, Radiomics\n\n\nNetworking lunch\nSession 3: Innovation breakthroughs for a fast-growing Life Sciences industry: an overview of Massachusetts and Belgium\n\nWelcoming and overview of the Massachussetts and Belgian ecosystems (MassBIO & BioWin/flanders.bio) \nBreak-out seminars on selected topics :  \n\nCell & Gene Therapy (Cellaion\, Novadip\, 2Bridge)\nImmuno-oncology (chair: ICON plc – Iteos therapeutics\, PDC Line Pharma\, ATB Therapeutics\, Celyad\, Elmedix)\nVaccines innovation (GSK\, Quantoom Biosciences\, Mithra\, Idevax)\nMedical Technology (MintT\, Spentys\, Nextgenics\, Omina Technologies)\n\n\nBreak-out B2Bs\n\n\n\n\nSession 4: -How industry and academia can unlock beneficial interactions with Harvard and MIT?\n\n\n\n\n\n\nIntroduction of the Harvard-MIT Belgian Society (HMBS)\, Introduction of Belgian Research Fellows\n\nVesicles for therapeutic delivery of bioproducts\, Harvard Medical School – Massachusetts General Hospital\, Department of Neurology\nDeep Learning for chemical reactivity prediction\, MIT – Department of Chemical Engineering\nDrug screens to target aggressive leukemia\, Harvard Medical School – Massachusetts General Hospital\nCryo-EM as a powerful tool for cancer drug discovery\, Harvard Medical School – Dana Farber Cancer Institute Department Cancer Biology\nRegeneration at our fingertips\, Harvard Medical School / Massachusetts General Hospital\nCardiovascular Research Center\nG-quadruplexes in human DNA\, NorthEastern University College of Science\, Department of Biology\n\n\n\n\n\n\n\n.        -Breakout Session: Synthetic Biology (MIT\, KULeuven\, Syngulon) \n\nNetworking drink\n\nWe look forward to meeting you on June 10th at MassBio Hub. The number of seats being limited we suggest you register already on the following link; https://forms.gle/Fa9UXTUXk6wLbZzV7 . 
URL:https://scienceinboston.com/event/life-sciences-day-belgium-the-health-biotech-valley-of-tomorrow/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20220610T091000
DTEND;TZID=America/Toronto:20220610T173000
DTSTAMP:20260501T042242
CREATED:20220519T181950Z
LAST-MODIFIED:20220519T181950Z
UID:27838-1654852200-1654882200@scienceinboston.com
SUMMARY:Life Sciences Day – “Belgium\, the Health & Biotech Valley of Tomorrow”
DESCRIPTION:Did you know that Belgium is a vibrant and innovative ecosystem in health and life sciences?  \nBelgium is serving as a covid vaccine production powerhouse to fight the pandemic. The Belgian biopharma industry has been the leader for the European market for the 5th year in a row. \nTop Belgian life sciences companies will host a full-day event at the MassBio Hub on June 10th with the aim to meet and engage US companies and to develop partnerships. This event is taking place within the biggest Belgian trade mission ever organized\, chaired by HRH Princess Astrid\, with a delegation of more than 250 companies. \nIt will be an opportunity to learn\, meet and network with CEOs of established and promising life science companies. (http://www.investinwallonia.be/key-sectors/life-sciences/belgian-economic-mission-life-sciences-usa?organization=3&application=#card-9 ) \nThe program includes conferences\, seminars and B2B meetings\, and\, will end with a pre-Bio networking drink. \nThe day will be divided in 4 different sessions  \n\nSession 1: Biomanufacturing in Belgium – an ecosystem that goes beyond the current assets\n\n\n\n\n\n\nPanel discussion 1 – Health challenges of today and tomorrow: the importance of biomanufacturing capabilities – 35 min with US/BE representatives of Mithra\, Kaneka-Eurogentec\, GSK\, Thermo Fisher\nPanel 2: Innovation in biomanufacturing – 35 min with US/BE representatives of UCB\, Univercells\, Takeda\, BioWin\n\n\n\n\n\n\nSession 2: Artificial Intelligence\, catalyst in Health & Life-Sciences\n\n\n\n\nPresentations by leading researchers followed by panel discussion with US/BE representatives of IMEC\, MIT\, N-Side\, Radiomics\n\n\nNetworking lunch\nSession 3: Innovation breakthroughs for a fast-growing Life Sciences industry: an overview of Massachusetts and Belgium\n\nWelcoming and overview of the Massachussetts and Belgian ecosystems (MassBIO & BioWin/flanders.bio) \nBreak-out seminars on selected topics :  \n\nCell & Gene Therapy (Cellaion\, Novadip\, 2Bridge)\nImmuno-oncology (chair: ICON plc – Iteos therapeutics\, PDC Line Pharma\, ATB Therapeutics\, Celyad\, Elmedix)\nVaccines innovation (GSK\, Quantoom Biosciences\, Mithra\, Idevax)\nMedical Technology (MintT\, Spentys\, Nextgenics\, Omina Technologies)\n\n\nBreak-out B2Bs\n\n\n\n\nSession 4: -How industry and academia can unlock beneficial interactions with Harvard and MIT?\n\n\n\n\n\n\nIntroduction of the Harvard-MIT Belgian Society (HMBS)\, Introduction of Belgian Research Fellows\n\nVesicles for therapeutic delivery of bioproducts\, Harvard Medical School – Massachusetts General Hospital\, Department of Neurology\nDeep Learning for chemical reactivity prediction\, MIT – Department of Chemical Engineering\nDrug screens to target aggressive leukemia\, Harvard Medical School – Massachusetts General Hospital\nCryo-EM as a powerful tool for cancer drug discovery\, Harvard Medical School – Dana Farber Cancer Institute Department Cancer Biology\nRegeneration at our fingertips\, Harvard Medical School / Massachusetts General Hospital\nCardiovascular Research Center\nG-quadruplexes in human DNA\, NorthEastern University College of Science\, Department of Biology\n\n\n\n\n\n\n\n.        -Breakout Session: Synthetic Biology (MIT\, KULeuven\, Syngulon) \n\nNetworking drink\n\nWe look forward to meeting you on June 10th at MassBio Hub. The number of seats being limited we suggest you register already on the following link; https://forms.gle/Fa9UXTUXk6wLbZzV7 . 
URL:https://scienceinboston.com/event/life-sciences-day-belgium-the-health-biotech-valley-of-tomorrow-2/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
END:VCALENDAR